Search research articles
Contact Us
Filters
Showing results (41-50 of 172) with videos related to
Page
of 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
November 8, 2019
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
Ricard Mesia, Paolo Bossi, Aaron R Hansen, et al.
Journal of the National Cancer Institute
|
February 22, 2021
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials
Zachary W Veitch, Daniel Shepshelovich, Christina Gallagher, et al.
Oral Oncology
|
January 17, 2022
Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma
Olivia Chin, Laila Alshafai, Brian O'Sullivan, et al.
Investigational New Drugs
|
March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Targeted Oncology
|
May 31, 2022
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study
Abdulazeez Salawu, Aaron R Hansen, Anna Spreafico, et al.
Cancer Medicine
|
December 17, 2021
Semen and serum platinum levels in cisplatin-treated survivors of germ cell cancer
Eoghan R Malone, Jeremy Lewin, Xuan Li, et al.
Cancer
|
April 2, 2021
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer
Shabbir M H Alibhai, Henriette Breunis, Aaron R Hansen, et al.
JCO Precision Oncology
|
August 2, 2021
Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment
Nazanin Aghel, Dakota Gustafson, Ashley Di Meo, et al.
Head & Neck
|
April 26, 2020
Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer
Christopher W Noel, Robert F Stephens, Jie Susie Su, et al.
Head & Neck
|
November 26, 2019
Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer
Robert F Stephens, Christopher W Noel, Jie Susie Su, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 172) with videos related to
Sort By:
Page
of 18
European Journal of Cancer (Oxford, England : 1990)
|
November 8, 2019
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
Ricard Mesia, Paolo Bossi, Aaron R Hansen, et al.
Journal of the National Cancer Institute
|
February 22, 2021
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials
Zachary W Veitch, Daniel Shepshelovich, Christina Gallagher, et al.
Oral Oncology
|
January 17, 2022
Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma
Olivia Chin, Laila Alshafai, Brian O'Sullivan, et al.
Investigational New Drugs
|
March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Targeted Oncology
|
May 31, 2022
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study
Abdulazeez Salawu, Aaron R Hansen, Anna Spreafico, et al.
Cancer Medicine
|
December 17, 2021
Semen and serum platinum levels in cisplatin-treated survivors of germ cell cancer
Eoghan R Malone, Jeremy Lewin, Xuan Li, et al.
Cancer
|
April 2, 2021
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer
Shabbir M H Alibhai, Henriette Breunis, Aaron R Hansen, et al.
JCO Precision Oncology
|
August 2, 2021
Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment
Nazanin Aghel, Dakota Gustafson, Ashley Di Meo, et al.
Head & Neck
|
April 26, 2020
Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer
Christopher W Noel, Robert F Stephens, Jie Susie Su, et al.
Head & Neck
|
November 26, 2019
Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer
Robert F Stephens, Christopher W Noel, Jie Susie Su, et al.
Page
of 18